IO Biotech, Inc.
NASDAQ:IOBT
1.19 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -86.083 | -71.458 | -67.879 | -12.042 | -10.743 |
| Depreciation & Amortization
| 0.756 | 0.54 | 0.002 | 0 | 0 |
| Deferred Income Tax
| 0.126 | 0.087 | -0.002 | 0 | 0 |
| Stock Based Compensation
| 8.059 | 7.04 | 1.791 | 0.064 | 0.131 |
| Change In Working Capital
| 5.862 | 4.192 | -0.776 | 0.148 | 0.893 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.126 | 0.077 | 3.406 | -0.475 | 0.103 |
| Other Working Capital
| 5.988 | 4.115 | -4.182 | 0.623 | 0.79 |
| Other Non Cash Items
| -0.457 | -0.13 | 26.218 | 1.874 | 0.828 |
| Operating Cash Flow
| -71.737 | -59.729 | -40.646 | -9.956 | -8.891 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.323 | -0.69 | -0.153 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -0.323 | -0.69 | -0.153 | 0 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 0 | -9.014 |
| Common Stock Issued
| 71.86 | 0 | 115.115 | 5.102 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -3.198 | 0 | 137.836 | -0.014 | 18.028 |
| Financing Cash Flow
| 71.86 | 0 | 252.951 | 5.102 | 9.014 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0.803 | -8.522 | -3.758 | 0.413 | -0.248 |
| Net Change In Cash
| 0.603 | -68.941 | 208.394 | -4.441 | -0.125 |
| Cash At End Of Period
| 143.193 | 142.858 | 211.799 | 3.405 | 7.846 |